LEADER 05283nam 22006611 450 001 9910961458903321 005 20230725054627.0 010 $a9781908986665 010 $a1908986662 010 $a9781908986689 010 $a1908986689 035 $a(CKB)3710000000083554 035 $a(EBL)3410366 035 $a(SSID)ssj0001084413 035 $a(PQKBManifestationID)11591854 035 $a(PQKBTitleCode)TC0001084413 035 $a(PQKBWorkID)11036415 035 $a(PQKB)11595446 035 $a(MiAaPQ)EBC3410366 035 $a(Au-PeEL)EBL3410366 035 $a(CaPaEBR)ebr10827997 035 $a(CaONFJC)MIL577732 035 $a(OCoLC)923424812 035 $a(Perlego)3168787 035 $a(EXLCZ)993710000000083554 100 $a20100804d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEvidence-based management of stroke /$f[edited by] Jose? Biller, Jose? M. Ferro 205 $aFirst edition. 210 1$aHarley :$ctfm Publishing,$d2011. 215 $a1 online resource (344 p.) 300 $aDescription based upon print version of record. 311 08$a9781903378762 311 08$a1903378761 320 $aIncludes bibliographical references and index. 327 $a""COVER FRONT""; ""Contents""; ""Foreword""; ""Contributors""; ""Acknowledgements""; ""Using evidence-based medicine""; ""Chapter 1 Thrombolysis in ischemic stroke""; ""Chapter 2 Management of stroke risk factors""; ""Chapter 3 Antithrombotic therapies in stroke prevention""; ""Chapter 4 Anticoagulant therapy in prevention of ischemic stroke""; ""Chapter 5 Interventions for acute ischemic stroke""; ""Chapter 6 Interventions for carotid artery disease and intracranial stenosis""; ""Chapter 7 Surgery for acute ischemic stroke"" 327 $a""Chapter 8 Management of ruptured cerebral aneurysms and aneurysmal subarachnoid hemorrhage""""Chapter 9 Management of spontaneous intracerebral hemorrhage""; ""Chapter 10 Cerebral venous sinus thrombosis""; ""Chapter 11 Ischemic stroke in children""; ""Chapter 12 Stroke in pregnancy and puerperium""; ""Chapter 13 Oral contraceptives, hormonal therapy and stroke""; ""Chapter 14 The management of cerebrovascular complications in cardiac procedures""; ""Chapter 15 Central nervous system vascular malformations""; ""Index""; ""COVER BACK"" 330 8 $aWinner of a HIGHLY COMMENDED AWARD in the Neurology category of the 2012 BMA Medical Book Competition. More than five million people die from stroke each year. Stroke is also the leading cause of adult disability, affecting over 20 million people worldwide, with two-thirds of stroke victims left permanently disabled. We now know that speed of intervention is critical and patient outcomes are determined by a very narrow therapeutic window, during which physicians need to be able to make their choice of treatment rapidly, based on the best evidence available. The purpose of this book is to review that evidence, for both medical and surgical therapies as well as preventative strategies, drawing on the expertise of leading international authorities to distinguish the issues for which there is a consensus on best practice from those for which the evidence remains inconclusive. For example, for patients with acute ischemic stroke the first choice is intravenous thrombolytic therapy, but does a treatment window of 0-3 hours deliver outcomes significantly better than one of 3-4.5 hours? Arterial hypertension is the single most important modifiable risk factor for ischemic stroke, but what are the effects of blood pressure reduction among acute stroke patients? How effective is blood pressure lowering in primary intracerebral hemorrhage? What are the arguments in favour of continuation versus temporary discontinuation of antihypertensive therapy immediately after acute ischemic stroke? Endovascular procedures (carotid angioplasty/stenting) are increasingly important but what do the data tell us about their safety? Or durability? How do they compare with carotid endarterectomy? The management of unruptured intracranial aneurysms is rife with controversies; clip, coil, wait and watch? The authors examine the evidence for and against. Other sections examine the impact of various risk factors, and special populations. A section on stroke after cardiovascular surgeries reviews the incidence and management of stroke following a whole range of procedures. Another examines special risks during pregnancy. Lastly, the book reviews our understanding of childhood stroke and presents current best practice recommendations for this most challenging group of patients. 606 $aCerebrovascular disease$xTreatment 606 $aEvidence-based medicine 606 $aCerebrovascular disease$xPrevention 615 0$aCerebrovascular disease$xTreatment. 615 0$aEvidence-based medicine. 615 0$aCerebrovascular disease$xPrevention. 676 $a616.8106 701 $aBiller$b Jose?$01604161 701 $aFerro$b Jose? M$01655560 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910961458903321 996 $aEvidence-based management of stroke$94367463 997 $aUNINA